Answers are grounded in this paper and cite their sources.
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR) agonist that is associated with sedative and analgesic sparing effects, reduced delirium and agitation, perioperative sympatholysis, cardiovascular stabilizing effects, and preservation of respiratory function. The aim of this review is to present the most recent topics regarding the advantages in using dexmedetomidine in clinical anesthesia and intensive care, while discussing the controversial issues of its harmful effects.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: